Title : Increased globotriaosylceramide levels in a transgenic mouse expressing human alpha1,4-galactosyltransferase and a mouse model for treating Fabry disease.

Pub. Date : 2011 Feb

PMID : 20961863






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Fabry disease is a lysosomal storage disorder caused by an alpha-galactosidase A (alpha-Gal A) deficiency and resulting in the accumulation of glycosphingolipids, predominantly globotriaosylceramide (Gb3). globotriaosylceramide galactosidase, alpha Mus musculus
2 Fabry disease is a lysosomal storage disorder caused by an alpha-galactosidase A (alpha-Gal A) deficiency and resulting in the accumulation of glycosphingolipids, predominantly globotriaosylceramide (Gb3). globotriaosylceramide galactosidase, alpha Mus musculus
3 Fabry disease is a lysosomal storage disorder caused by an alpha-galactosidase A (alpha-Gal A) deficiency and resulting in the accumulation of glycosphingolipids, predominantly globotriaosylceramide (Gb3). globotriaosylceramide galactosidase, alpha Mus musculus